hipages Group launches up to 10% on-market share buy-back starting May 2026
hipages Group (ASX:HPG) has kicked off an on-market buy-back of up to 10% of its shares, signalling confidence in its undervalued stock amid strong cash flow and growth.
- On-market buy-back of up to 10% of issued capital
- Buy-back funded from existing cash reserves
- Shares deemed materially undervalued by Board
- Strong cash flow and profitable growth cited
- Buy-back to run up to 12 months from mid-May
Board Sees Undervaluation, Moves to Buy Back Shares
hipages Group Holdings Ltd (ASX:HPG) has announced an on-market share buy-back program targeting up to 10% of its issued share capital, commencing on or after 14 May 2026 and running for up to 12 months. The move reflects the Board’s conviction that the company’s shares are materially undervalued relative to its strong growth trajectory and cash-generative business model.
Chair Inese Kingsmill emphasised that the buy-back represents an efficient capital management strategy given hipages’ robust balance sheet and free cash flow generation. The buy-back will be funded entirely from existing cash facilities, avoiding the need for external financing or debt.
Financial Strength Underpinning Buy-Back Decision
hipages’ recent financial performance supports the Board’s confidence. The company reported an 11% revenue increase to A$44.9 million and a 29% jump in EBITDA to A$11.18 million in its latest half-year results, alongside a net profit surge to A$2.75 million. This momentum was driven by strategic pricing changes and expansion in New Zealand, with a strong cash position of A$31.1 million and zero debt providing ample flexibility for capital returns.
This cash strength follows a period of significant free cash flow growth, with FY25 seeing a 162% surge to A$5.6 million, underpinned by a successful migration to a single tradie platform and subscription model shifts. These operational milestones have set the stage for the current buy-back initiative, which aims to enhance shareholder value by reducing share count amid favourable market conditions.
Buy-Back Execution and Market Impact
The buy-back will be conducted through ordinary trading on the ASX, with the exact number and timing of shares repurchased contingent on market conditions. hipages reserves the right to vary, suspend, or terminate the program at any time, providing flexibility to respond to market dynamics.
Investors should note that while buy-backs can signal management’s confidence and potentially support share prices, the impact depends on execution scale and prevailing market sentiment. Given hipages’ recent strategic moves, including its expansion into tradie insurance via a stake in VIZ Insurance, the buy-back complements a broader strategy to deepen platform offerings and strengthen customer retention.
Bottom Line?
hipages’ buy-back signals Board confidence in undervalued shares, backed by solid cash flow and growth, but execution timing will be key to market reaction.
Questions in the middle?
- How aggressively will hipages execute the buy-back amid market volatility?
- Could the buy-back signal a shift in capital allocation away from acquisitions?
- What impact will the buy-back have on hipages’ share liquidity and valuation?
